Disease: Multiple endocrine neoplasia type 2A
- <em>Letter to the Editor:</em> The Somatic <em>RET</em> M918T Variant May Modify the Natural History of Germline <em>RET</em> L790F MEN2-Related Medullary Thyroid Carcinoma
- "Graded early warning system" of <em>RET</em> germline mutation carriers in MEN2A/MEN2B families and total thyroidectomy (report of 7 cases)
- 30 years of prophylactic thyroidectomy for hereditary medullary thyroid cancer : A milestone in translational medicine
- A case of multiple endocrine neoplasia syndrome type 2A combined with autoimmune polyendocrine syndrome type
- A case of multiple endocrine neoplasia syndrome type 2A combined with autoimmune polyendocrine syndrome type Ⅲ
- A Case Report of Multiple Endocrine Neoplasia Type 2A(MEN2A)Diagnosed with Medullary Thyroid Carcinoma
- A Case Study of Multiple Endocrine Neoplasia Type 2A
- A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
- A Familial Case of Multiple Endocrine Neoplasia 2A: From Morphology to Genetic Alterations Penetration in Three Generations of a Family
- Accelerated MEN 2A in Homozygous RET Carriers in the Context of Consanguinity
- Accelerated MEN2A in homozygous RET carriers in the context of consanguinity
- Anesthesia and Outcome of 33 Surgeries in 24 Multiple Endocrine Neoplasia Type 2A (MEN2A) Patients: A National Rare Disease Center's Experience
- Approach to the Patient: Insulinoma
- Benzene and cause-specific mortality in an Italian national cohort of exposed workers through a proportions analysis
- C634Y mutation in RET-induced multiple endocrine neoplasia type 2A: A case report
- Calvarial metastasis from malignant pheochromocytoma associated with multiple endocrine neoplasia
- Clinic Heterogeneity and Management of Pediatric Patients With Germline RET Proto-oncogene Mutation: Single-center Experience
- Clinical and genetic analysis of seven Chinese pedigrees affected with multiple endocrine neoplasia type 2A with cutaneous lichen amyloidosis
- Clinical and laboratory features of hereditary pheochromocytoma and paraganglioma
- Clinical characteristics of a large familial cohort with Medullary thyroid cancer and germline Cys618Arg <em>RET</em> mutation in an Israeli multicenter study
- Clinical presentation of MEN 2A in index vs. non-index patients
- Comparing nodal with primary tumor desmoplasia uncovers metastatic patterns in multiple endocrine neoplasia 2B
- Correlation analysis of clock genes and MEN2 medullary thyroid carcinoma
- Critically evaluated key points on hereditary medullary thyroid carcinoma
- Developing Dynamic Structure-Based Pharmacophore and ML-Trained QSAR Models for the Discovery of Novel Resistance-Free RET Tyrosine Kinase Inhibitors
- Developing Dynamic Structure-Based Pharmacophore and ML-Trained QSAR Models for the Discovery of Novel Resistance-Free RET Tyrosine Kinase Inhibitors Through Extensive MD Trajectories and NRI Analysis
- Diagnosis and treatment of bilateral adrenal pheochromocytoma with RET gene mutation combined with medullary sponge kidney: A case report
- Diagnostic and Surgical Challenges Associated With Sporadic Multiple Endocrine Neoplasia 2A Presenting as Non-syndromic Primary Hyperparathyroidism
- Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple Endocrine Neoplasia Type 1 Syndrome
- Elevated Calcitonin Levels in a Patient With a Pheochromocytoma: A Case Report
- Familial parathyroid tumours-comparison of clinical profiles between syndromes
- Fibroblast Activation Protein Inhibitor Imaging and Therapy in a Patient With Multiple Endocrine Neoplasia Type 2A Syndrome
- Fractures in type 2 diabetes confer excess mortality: The Dubbo osteoporosis epidemiology study
- Genetic diagnosis of endocrine disorders in Cyprus through the Cyprus Institute of Neurology and Genetics: an ENDO-ERN Reference Center
- Genotype-specific development of MEN 2 constituent components in 683 RET carriers
- Germline founder variant c.1998delinsTTCT in the RET oncogene: a cohort study in 15 Belgian families
- Hereditary medullary thyroid cancer
- Impact of Early Diagnostic and Therapeutic Interventions and Clinical Course in Children and Adolescents with Multiple Endocrine Neoplasia Types 1 and 2
- Incidence of medullary thyroid carcinoma and Hirschsprung disease based on the cosmos database
- Individualization of treatment in sporadic and hereditary medullary thyroid cancer
- Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of CDC73 Gene and Parafibromin-Deficient Tumours
- Invited Commentary: Less than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis
- Left anterior descending artery disease in a 27-year-old with multiple endocrine neoplasia, type 2A: A case report
- Lived experiences of undergoing regular tumor screening in patients with multiple endocrine neoplasia types 1 and 2 (MEN1/MEN2)
- Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing
- Management of medullary carcinoma of the thyroid: a review
- Medullary thyroid cancer with RET V804M mutation: more indolent than expected?
- Medullary thyroid carcinoma: a narrative historical review
- MEN2A syndrome presenting as medullary thyroid cancer metastasizing into the pheochromocytoma
- Menin Loss in Pheochromocytoma of Multiple Endocrine Neoplasia Type 1
- Molecular and Clinical Spectrum of Primary Hyperparathyroidism
- Multiple endocrine neoplasia 2A presenting in a family with a history of Hirschprung's disease
- Multiple endocrine neoplasia and very early onset inflammatory bowel disease. An unexpected association
- Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B
- Multiple endocrine neoplasia type 2 (MEN2) and RET specific modifications of the ACMG/AMP variant classification guidelines and impact on the MEN2 RET database
- Multiple endocrine neoplasia type 2 and autoimmune polyendocrine syndromes (type 1 diabetes mellitus and Graves' disease) in a 16-year-old male with Kabuki syndrome
- Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results
- Multiple endocrine neoplasia type 2A syndrome presenting with corneal nerve thickening
- Multiple endocrine neoplasia type 4 & primary hyperparathyroidism: What the surgeon needs to know
- Multiple endocrine neoplasia type 4 & primary hyperparathyroidism: What the surgeon needs to know
- Multiple, bilateral conjunctival tumors-A 27-year-old female patient with MEN2B
- No relevant spectator impact on home advantage in male and female professional volleyball - A longitudinal multilevel logistic model analysis over 25 years
- Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis
- Oncological features of sporadic vs. hereditary pediatric medullary thyroid cancer
- Paraganglioma
- Paraganglioma
- PDP type brain tumor in association with multiple endocrine neoplasia type 1
- Pediatric head and neck manifestations associated with multiple endocrine neoplasia syndromes
- Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades
- Pediatric Thyroidectomy: Experience From a Portuguese Hospital
- Pheochromocytoma associated with primary hyperparathyroidism and type 1 neurofibromatosis
- Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate?
- Pheochromocytoma triggered by coronavirus disease 2019: a case report
- Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930-2021: A Nationwide Population-Based Retrospective Study
- Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective Study
- Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark: A Nationwide Population-Based Retrospective Study in Denmark 1930-2021
- Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome
- Prominent corneal nerves in pure mucosal neuroma syndrome, a clinical phenotype distinct from multiple endocrine neoplasia type 2B
- Quality of work community and workers' intention to retire
- Rare and aggressive metastatic pheochromocytoma recurrence in a patient with MEN 2A syndrome
- Recurrent ipsilateral pheochromocytoma in carriers of RET p.Cys634 missense mutations
- Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue
- RET 634 germline/gonadal mosaicism generating a second pathogenic amino acid change in multiple endocrine neoplasia type 2A
- RET c.1901G>A and Novel SLC12A3 Mutations in Familial Pheochromocytomas
- RET gene mutational diagnosis and precision medicine in Mexico
- RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions
- Sex differences in MEN 2A penetrance and expression according to parental inheritance
- Simultaneous unilateral laparoscopic adrenalectomy for pheochromocytoma and thyroidectomy in MEN 2A and MEN 2B syndrome
- Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
- Surgical aspects and controversies in the management of medullary thyroid cancer
- Surgical treatment of pheochromocytoma
- Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys
- Temporal trends in referrals of RET gene carriers for neck surgery to a tertiary surgical center in the era of international management guidelines
- The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative Medicine
- The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype?
- The protean role of Val804Met RET mutation in thyroid neoplasms: An example of a "MEN2C" syndrome?
- The role of prophylactic parathyroidectomy during thyroidectomy for MTC in patients with MEN2A syndrome
- The trends in early precision diagnosis and treatment strategies of multiple endocrine neoplasia type 2
- Two sisters diagnosed with familial paraganglioma syndrome type 1 (FPGL1) and multiple endocrine neoplasia type 2A (MEN2A)
- Unexpected structures formed by the kinase RET C634R mutant extracellular domain suggest potential oncogenic mechanisms in MEN2A